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1. Introduction  
Urinary tract infections (UTIs) are among the most common conditions requiring medical 
treatment with 6-10% of all young females demonstrating bacteriuria (Raz 2001). The 
incidence of UTIs increases with age and 25-50% of females aged 80 or more have 
bacteriuria (Abrutyn et al. 1988). UTIs occur as a result of interactions between the 
uropathogen and host and their pathogenesis involves several processes. Initially the 
uropathogen attaches to the epithelial surface; it subsequently colonises and disseminates 
throughout the mucosa causing tissue damage. After the initial colonisation period, 
pathogens can ascend into the urinary bladder resulting in symptomatic or asymptomatic 
bacteriuria. Further progression may lead to pyelonephritis and renal impairment. Specific 
virulence factors residing on the uropathogen’s membrane are responsible for bacterial 
resistance to the normally effective defence mechanisms of the host. Recently, bacterial 
adhesins and their associated epithelial binding sites have been identified and natural anti-
adherence mechanisms are currently under investigation. 
An understanding of pathogenic and anti-adherence mechanisms may allow physicians to 
develop appropriate strategies for UTI prevention and adequate management protocols. In 
the present chapter we discuss current concepts on the pathogenesis of UTIs with particular 
emphasis on pathogenic bacteria, virulence factors, predisposing factors, natural defences 
within genitourinary tract and consequences when these defence mechanisms are altered. 
2. Routes of infection 
In healthy patients most uropathogens originate from rectal flora and enter the urinary tract 
via the urethra into the bladder (Handley et al. 2002). This is known as the ascending route 
and uropathogens initially adhere to and colonise urothelium of the distal urethra (Fig.1). 
Enhancement of this route is exacerbated in patients with soiling around the perineum, in 
patients with urinary catheters and in females that use spermicidal agents (Foxman 2002). In 
patients with established cystitis up to 50% of infections may ascend into the upper urinary 
tracts and most episodes of pyelonephritis are caused by ascension of bacteria from the 
bladder through the ureter and into the renal pelvis (Busch and Huland 1984). Bacterial 
ascent is aided by conditions such as pregnancy and ureteral obstruction as these conditions 
inhibit ureteral peristalsis. Bacteria that reach the renal pelvis can penetrate the renal 
parenchyma through the collecting ducts and disrupt the renal tubules. 
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In healthy individuals infection of the kidney through the haematogenous route is 
uncommon. Occasionally, the renal parenchyma may be breeched in patients with 
Staphylococcus aureus bacteraemia or Candida fungaemia that originate from oral sources 
in immunosuppressed patients (Smellie et al. 1975). On rare occasions bacteria from adjacent 
organs may penetrate the urinary tract via the lymphatics. Conditions associated with the 
lymphatic route are retroperitoneal abscesses and severe bowel infections. 
 
 
Fig. 1. Urinary tract infections may arise from ascending, haematogenous or lymphatic 
routes. Ascending routes of infection are most common among patients with an established 
UTI. 
3. Urinary pathogens 
3.1 Pathogenic bacteria  
E. coli accounts for 85% of community acquired and 50% of hospital acquired urinary tract 
infections. Within the E.coli species a number of subgroups (O1, O2, O4, O6, O7, O8, O18, 
O25, O68 and O75) are frequently isolated from patients with UTI (Brooks et al. 1981, 
Gruneberg 1969, Roberts and Phillips 1979, Vosti et al. 1964). Gram negative bacteria such as 
Klebsiella and Proteus; and Gram positive Enterococcus faecalis and Staphylococcus 
saprophiticus are causative agents for the remainder of community acquired infections 
(Kennedy et al. 1965). The remainder of hospital acquired infections usually occur after 
colonisation with Klebsiella, Enterobacter, Citrobacter, Serratia, Pseudomonas aeruginosa, 
Providencia, E. faecalis, or S. epidermidis (Kennedy et al. 1965). Notably, the patient’s age 
may influence they type of infective organism present with Staphylococcus saprophiticus 
now accounting for 10% of UTIs in young females compared to less than 1% in elderly 
female patients. 
3.2 Uncomplicated UTIs  
UTIs can be classified as either complicated or uncomplicated depending on underlying 
host factors and on underlying uropathogens as illustrated in table 1. The aetiology of 
uncomplicated UTIs has remained constant over the last 2 to 3 decades with E. coli 
accounting for the vast majority of cases. Previously, female patients with uncomplicated 
UTIs generally remained sensitive to a trimethoprim-sulfamethoxazole combination and the 
traditional approach to therapy had been an empirical short-course treatment with this 
antibiotic regimen (Hooton and Stamm 1997, Stamm and Hooton 1993). Unfortunately, a 
number of more recent studies have demonstrated increasing antimicrobial resistance 
among uropathogens causing uncomplicated cystitis and traditional antibiotic regimens 
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have been questioned (Gupta et al. 1999). One study investigated antimicrobial resistance 
among 4000 female petients with UTI isolates over a 5 year experimental time period. 
Results from this study demonstrated an increase in antimicrobial (E. coli) resistance from 
9% to 18% in patients treated with trimethoprim-sulfamethoxazole (Gupta et al. 1999). In 
addition, resistance to cephalothin (a first generation cephalosporin) increased from 20% to 
28% and resistance to ampicillin increased from 26% to 34%. Notably, resistance to 
nitrofrantoin and ciprofloxacin remained <1% after the 5 year period. This increase in 
bacterial resistance has been attributed to recent administration of trimethoprim-
sulfamethoxazole, diabetes mellitus, recent hospitalisation and recent administration of any 
other antibiotic (Wright et al. 1999). 
Clinical implications for increasing resistance trends include a potential alteration to 
antibiotic regimens commonly administered for treating uncomplicated UTIs. One study 
demonstrated a greater cure rate after a 7-day course of ciprofloxacin compared to a 14-day 
course of trimethprim-sulfamethoxazole in premenopausal females with uncomplicated 
pyelonephritis (Talan et al. 2000). In this study it is also notable that E. coli resistance to 
trimethoprim-sulfamethoxazole was significantly greater (18%) compared to ciprofloxacin 
(0%). Lower cure rates for uncomplicated UTIs in females treated with trimethoprim-
sulfamethoxazole have also been demonstrated in another study where failure rates 
increased from 3% to 13% in sensitive E.coli strains and from 27% to 40% in resistant strains 
(McCarty et al. 1999). Based on these studies antimicrobial treatment with either a 
fluoroquinolone, nitrofurantoin or fosfomycin are currently recommended for 
uncomplicated UTIs. Importantly, clincians should also be aware of the antimicrobial 
spectrum for these agents prior to administration as nitrofurantoin is not effective for 
treating uncomplicated pyelonephritis but highly effective for treating acute cystitis. 
Recurrent uncomplicated UTIs occur after 3 to 6 months in 25% to 35% of patients after their 
initial UTI. The second strain is caused by an identical strain to the first UTI in up to 60% of 
patients with recurrent UTI (Ronald 2003).  
3.3 Complicated UTIs  
Underlying host factors such as age, catheterisation, diabetes mellitus and spinal cord injury 
predispose to complicated UTIs (Fig. 2). In complicated UTIs less virulent uropathogens 
(that rarely cause disease in a normal urinary tract) can cause significant damage to an 
abnormal urinary tract. Studies have demonstrated associations between Group B 
streptococcal bacteraemia, Candida and Enterococci with complicated UTIs in the elderly 
population (Khan and Ahmed 2001, Munoz et al. 1997).  
 
 
Fig. 2. Predisposing factors for complicated UTIs. 
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Children with comorbidities are more likely to develop complicated UTIs and 
Staphylococcus aureus is the most frequently isolated micro-organism in paediatric patients 
with indwelling catheters (Schlager 2001). Candida and coagulase-negative staphylococci 
are associated with complicated UTIs after instrumentation of the paediatric urinary tract. 
Of note, enterobacteriaceae are the most frequently isolated uropathogen in children with 
uncomplicated UTIs (Schlager 2001).  
UTIs are among the top 10 complicating illnesses in patients with diabetes mellitus with E. 
coli, Klebsiella, Group B Streptococci and Enterococcus among the common uropathogens 
(Ronald and Ludwig 2001). In fact, Group B Streptococcus and Klebsiella are 2-3 times more 
common in patients with diabetes mellitus than in patients without the condition (Ronald 
and Ludwig 2001). However, E. coli remains the most causative uropathogen for UTIs in 
patients with diabetes as demonstrated in one prospective study where E. coli was isolated 
in 56.1% of diabetic patients with a UTI (Bonadio et al. 1999). There is a higher rate of 
bladder catheterisation in patients with diabetes and this factor may partially account for the 
higher incidence in this patient cohort (Ronald 2003). 
Common uropathogens causing complicated UTIs among patients with spinal cord injuries 
and indwelling catheters include E. coli, Pseudomonas and Proteus mirabilis (Mobley et al. 
1994). The latter is particularly associated with complicated UTIs as it possesses unique 
virulence factors that enhance its invasive potential (Coker et al. 2000). One study 
demonstrated a significant increase in nosocomial UTIs from 2.63 of 1000 patient days to 
4.35 of 1000 patient days over a 9 year period (p<0.003). Notably, 88% of nosocomial UTIs in 
this study were catheter related (Bronsema et al. 1993). 
 
Pathogens in uncomplicated UTIs Pathogens in complicated UTIs 
Escherichia coli Escherichia coli 
Staphylococcus saprophyticus Kelbsiella 
Kelbsiella Enetrobacter cloacae 
Enterococcus faecalis Serratia marcescens 
 Proteus mirabilis 
 Pseudomonas aeruginosa 
 Enterococcus faecalis 
 Group B streptococci 
Table 1. Underlying uropathogens commonly isoloated in complicated and uncomplicated 
urinary tract infection (UTI) (Ronald 2003). 
4. Bacterial adherence mechanisms 
4.1 Virulence factors   
Bacterial virulence factors play a significant role in determining whether an organism will 
invade the urinary tract and the level of infection acquired. Uropathogenic E. coli (UPEC) is 
present within bowel flora and pathogenic strains of this microorganism can infect the 
urinary tract by expressing specific virulence factors that permit adherence and colonisation 
of the lower urinary tract (Schlager et al. 2002, Yamamoto et al. 1997). Adherence of the 
micro-organism is dependent on 3 important environmental characteristics; firstly the 
bacteria’s own adhesive characteristics, secondly the receptive features of the urothelium 
and finally the fluid that is present between both surfaces (Schaeffer et al. 1981). Bacteria 
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will migrate proximally and precipitate a host derived inflammatory response after 
adhering to the mucosal surface. 
Adhesins found on the surface of the bacterial membrane are responsible for initial 
attachment onto urinary tract tissues (Mulvey 2002) (Fig. 3).  
 
 
Fig. 3. Adhesins on the uropathogen are responsible for attachment of the bacteria to the 
uroepithelial cell membrane of the host.  
Adhesins are classified as fimbrial or afimbrial, depending on whether the adhesin is 
displayed as part of a rigid fimbria or pilus. Fimbriae and pili are surface glycoproteins that 
function as ligands for glycolipid and glycoprotein receptors on uroepithelial cells. Bacteria 
may produce 100-400 pili on the same cell and other cells can produce the same pilus type. 
Each pilus is 5-10 μm in diameter and up to 2 μm in length (Klemm 1985). A pilus is 
composed of subunits referred to as pilin and they are classified as either mannose sensitive 
or mannose resistant, based on their ability to mediate haemagglutination of erythrocytes. 
The most common types of pili are types 1, P and S. Assemblance of pili within the urinary 
tract is mediated by the ‘chaperone/ usher pathway’ where periplasmic chaperones such as 
P pilus chaperone ‘PapD’ and type 1 pilus chaperone ‘FimC’ possess two immunoglobulin 
(Ig)-like domains that are oriented to form a boomerang like shape (Kau et al. 2005, Kuehn 
et al. 1993, Lau et al. 2005). These chaperones are important for binding with pilus subunits 
to form stable complexes. The FimC chaperone accelerates the folding of type 1 pilus 
subunits to strengthen its binding process after its initial attachment process (Vetsch et al. 
2004). 
4.2 Type 1 pili  
Type 1 pili are also referred to as mannose sensitive pili and they are commonly expressed 
in pathogenic and non pathogenic strains of E. coli. They are termed mannose sensitive as 
haemagglutination of erythrocytes is inhibited in the presence of mannose (Reid and Sobel 
1987). Type 1 pili are composed of a helical rod with repeating Fim A subunits that are 
bound to a distal tip structure containing the Fim H adhesin (Jones et al. 1995). During the 
colonisation process Fim H adhesins bind to mannosylated receptors that are found on the 
host’s uroepithelium. An inflammatory process occurs shortly after this binding process has 
been initiated. A number of studies have demonstrated that interactions between the Fim H 
adhesin and epithelial cells on the bladder’s surface are essential for colonisation and 
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infection of bladder epithelium with strains of uropathogenic E. coli (Sun 1996, Wu et al. 
1996). This specific ‘adhesin-epithelial cell’ binding process occurs when type 1 pili bind to 
uroplakin 1a (UP1a) and uroplakin 1b (UP1b) (Malaviya and Abraham 1998). (Fig. 4) 
Uroplakins are membrane proteins that are found on umbrella cells which line the luminal 
surface of the urinary bladder. Initially adhesin binding mechanisms were investigated in a 
mouse cystitis model where numerous bacteria attached to the urothelial surface of the 
mouse urinary tract shortly after an inoculation period. Scanning electron microscopy of the 
urothelial layers demonstrated that Fim H containing pili bound to the central cavity of 
uroplakin hexameric rings and this binding process is responsible for the initial steps 
leading to active UTI (Mulvey et al. 1998). 
 
 
Fig. 4. During the colonisation period FimH adhesins bind to umbrella cells via uroplakin 1a 
and uroplakin 1b membrane receptors. 
After binding to the epithelial surface the activated Fim H adhesins migrate towards deeper 
urothelial layers and penetrate the cell membrane (Mulvey et al. 2000). Once the 
uropathogen is intracellular the invasive process continues as bacteria proliferate within the 
cytosol to form clusters (Anderson et al. 2004b). Eight hours after inoculation the phenotypic 
appearance of the bacteria changes to an engulfing ‘biofilm’ like structure that protects 
against the host’s immune response and shields the uropathogen from its surrounding 
environment (Justice et al. 2004) (Fig. 5). A decrease in the rate of bacterial proliferation will 
allow for effective production of a ‘biofilm matrix’. This matrix can prevent the host’s 
neutrophils from penetrating its surface. The ‘biofilm’ concept stems from the idea that 
bacteria co-operate with one another to remain viable and proliferate after attaching to a 
suitable substrate. Previously, it has been demonstrated that biofilms play an important role 
in a number of disease processes (Kau et al. 2005, Parsek and Singh 2003). Bacterial biofilms 
can form within infected urinary tract calculi, during Pseudomonas infections in patients 
with cystic fibrosis and in infective endocarditis. During the disease process biofilms form 
irreversible associations with their host by forming extracellular polysaccharides that have 
specialised functions (Justice et al. 2004).   
Biofilms can form on many different types of bacteria however the sequence of events 
during the ‘formation process’ remains similar in all bacteria. Firstly, bacteria express 
extracellular polymeric substances that are initially reversible and subsequently become 
irreversible. Bacteria that have irreversibly attached to a surface will serve as a nidus for 
continued replication and recruitment of other bacteria. Irreversible attachment is usually 
established after 24 hours where the bacteria will develop into a complicated ‘tower’ like 
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structure and become filamentous (up to 70 µm in length). Morphological changes allow the 
uropathogen to evade the host’s immune response (Justice et al. 2004). Bacteria that have 
clustered will eventually detach from their group, become motile and flee the host cell. 
Bacterial adherence and replication will recur after the uropathogen escapes its intracellular 
environment and this effective replication process will allow bacterial invasion to persist 
(Anderson et al. 2004a) (Fig. 5). 
 
 
Fig. 5. After attaching to the epithelial surface the uropathogen will enter the cytosol (A). 
Intracellular bacteria rapidly proliferate within the first 24 hours (B). Subsequently, 
proliferation rate decreases and a protective biofilm matrix forms (C). Morphological 
changes allow the uropathogen to evade the host’s immune response. Uropathogens that 
have clustered become motile and detach from the biofilm to disperse (D). 
4.3 P Fimbriated pili  
P fimbriated pili or mannose resistant strains of E. coli are associated with uncomplicated 
pyelonephritis as the receptor for P fimbriae is the major glycolipid component present on 
renal cell membranes (Mulvey 2002). They are termed mannose resistant as they are not 
affected by mannose during the haemagglutination process for human erythrocytes 
(Vaisanen et al. 1981). PapG is an adhesin found at the tip of the pilus and it recognizes the 
ǂ-d-galctopyranosyl-(1-4)-ǃ-d-galctopyranoside receptor which is found on P-blood group 
antigens on the host’s uroepithelium (Kallenius et al. 1981) (Fig. 6). Mannose resistant 
adhesins that do not demonstrate digalactoside-binding affinity are referred to as ‘X’ 
adhesins. A correlation between severe UTIs and bacterial adherence was first identified in 
1976 (Eden et al. 1976). Strains of uropathogenic E. coli in girls with established 
pyelonephritis had an adhesive ability of 70-80% compared to 10% in strains that caused 
asymptomatic bacteriuria. P pili were present in 91% of strains that caused pyelonephritis 
compared to a prevalence of 7% in bowel isolates from healthy children (Eden et al. 1976). 
Although mannose resistant haemagglutinins (MRHA) are associated with pyelonephritis it 
is important to note that no link exists between MRHA and renal scarring.  
4.4 Phase variation  
Interestingly, in vivo studies have shown that environmental factors are responsible for 
rapid changes in pili in E. coli isolates.  This transformation process is known as known as 
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Fig. 6. P fimbiae bind to the ǂ-d-galctopyranosyl-(1-4)-ǃ-d-galctopyranoside receptor on the 
host’s renal epithelial cell via the PapG adhesin. 
phase variation and it involves alternating periods of piliated and nonpiliated adhesins 
during in vivo E. coli infection (Hultgren et al. 1986, Schaeffer et al. 1987). One study showed 
phase variation of pili using indirect immunofluorescense assays of voided urine in human 
patients. Analysis of the urine samples showed type 1 pili in 31 of 41 samples and P pili in 6 
of 18 samples with piliation status varying from predominantly piliated to nonpiliated cells 
(Kisielius et al. 1989). These results demonstrated that type 1 and P pili are expressed and 
subject to phase variation in vivo during acute UTIs. The process of phase variation among 
adhesins has notable clinical implications. Importantly, the presence of type 1 pili may 
facilitate adherence and colonisation of the host’s mucosa in the lower urinary tract. 
However, P pili may predominate as the infective process progresses and ascends. This 
transformation process occurs because primary mediators for the attachment of P pili to 
their glycolipid receptors are found within the kidney (Mulvey et al. 1998). 
4.5 Cell receptivity  
Epithelial cell receptivity also plays an important pathogenic role in female patients that are 
susceptible to recurrent UTI. The receptivity concept was established after vaginal epithelial 
cells were collected from patients susceptible to recurrent UTI with E. coli and compared 
with control samples that were resistant to UTI (Fowler and Stamey 1977). Results from this 
study demonstrated that strains of E. coli associated with cystitis ardently adhered to 
vaginal epithelial cells of susceptible females. Notably, buccal cell receptivity is also 
increased for different strains of E. coli in females with increased vaginal cell receptivity. 
These findings indicate a genotypic trait as the increase in receptor sites for strains of E. coli 
is not confined to the vagina in females with recurrent UTIs. Further analysis of this genetic 
concept by assessing human leukocyte antigens (HLAs) in females with recurrent UTIs has 
demonstrated that HLA-A3 may be a contributing factor. It has also been shown that a 
greater number of uropathogens attach to epithelial cell surface in females that are greater 
than 65 years of age compared to premenopausal females (i.e. age 18-40) (Schaeffer et al. 
1983). 
5. Predisposing factors for pathogenic adherence 
5.1 Alterations to the host’s natural defence mechanisms  
Normal flora around the vaginal introitus, periurethral region and urethra include 
microorganisms such as lactobacilli, coagulase negative staphylococci and streptococci that 
www.intechopen.com
 
The Pathogenesis of Urinary Tract Infections 
 
109 
form a barrier against pathogenic colonisation. Alterations in the vaginal mucosa and 
decreases in its pH are thought to play an important role for with coliforms (Hooton et al. 
1996a). Acute disruptions to this mucosal barrier are frequently attributed to spermicidal 
and antimicrobial agents that alter normal flora and induce increased receptivity for 
uropathogens (Hooton et al. 1996a). Host factors that contribute to the disruption of this 
mucosal barrier are illustrated in table 2. 
Comorbidities such as diabetes mellitus, sickle cell disease, hyperphosphataemia, gout and 
analgesics are also associated with altering the host’s natural defence mechanisms 
(Freedman 1975). The incidence of pyelonephritis is up to fivefold higher in diabetics 
compared to non diabetic patients (Nicolle et al. 1996). Furthermore, female patients with 
diabetes mellitus are 3 times more likely to develop pyelonephritis compared to male 
patients with the condition (Nicolle et al. 1996). Diabetes also predisposes patients to more 
complicated UTIs with an inflammatory urothelial response occurring in the upper tracts of 
up to 80% of diabetic patients with UTIs (Forland et al. 1977, Stapleton 2002). In addition, 
UTIs in this patient cohort are often caused by atypical organisms and complications may 
progress to include papillary necrosis, perinephric abscesses or multisystemic infections 
(Stapleton 2002). 
Urinary tract obstruction and stasis of urine flow can significantly alter the host’s defence 
mechanisms and both factors strongly predispose to complicated UTIs (Hooton 2000). 
During the obstructive process local mucosal defence mechanisms are disturbed as the 
epithelial lining over-distends and pooled urine functions as a mean for bacterial growth 
and proliferation (Hooton et al. 2000). Urinary catheters, particularly in patients with high 
residual volumes, are also ideal media for uropathogens to colonise the urinary tract. 
Finally, fistulae can facilitate direct access into the genoitourinary tract via the 
gastrointestinal system. 
 
Genetic Biological Behavioural Others 
Blood group antigen 
Congenital 
abnormalities 
Sexual intercourse 
Decreased 
mental status 
Non-secretor status Urinary obstruction Use of diaphragm  
Increased density of 
adhesion receptors 
Calculi Use of spermicides  
 Diabetes mellitus Antimicrobial use  
 Anatomical   
 Residual urine   
 Atrophic vaginitis   
 Urinary incontinence   
 Prior history of UTI   
 
Maternal history of 
UTI 
  
 Urinary catheters   
 Stents   
 
Immunological 
deficiency (HIV) 
  
 Renal transplant   
Table 2. Host factors that contribute to the pathogenesis of UTIs in female patients. 
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5.2 Anatomical and physiological factors  
It is widely acknowledged that a number of factors contribute to a greater prevalence in 
UTIs in females compared to males. In particular, female pelvic anatomy plays an important 
predisposing role for recurrent UTIs in female patients. One study investigated differences 
in perineal anatomical measurements and voiding characteristics in 100 females with a 
history of recurrent UTIs and in 113 females with no prior history of UTIs. Analysis of the 
results demonstrated that the urethra and anus were significantly closer together in cases of 
UTI (4.8 ± 0.6cm) compared to controls (5.0 ± 0.7cm, p= 0.03) (Hooton 2000). Other 
important physiological and anatomical factors that predispose to bacterial adherence in 
females (compared to males) include a drier urethral meatus, a shorter urethra and the 
absence of antibacterial properties provided by prostatic fluid (Lipsky 1989).  
5.3 Spermicidal compounds  
Nonoxynol-9 is a non-ionic surfactant that is the most active ingredient found in spermicidal 
compounds in the USA. Results from in vitro studies have shown that it is less active against 
uropathogenic bacteria compared to Lactobacillus (Hooton et al. 1991a, McGroarty et al. 
1990) with hydrogen peroxide-producing strains being particularly susceptible (Hooton et 
al. 1991a). Therefore, it appears that vaginal colonisation with hydrogen peroxide vaginal 
strains of lactobacilli may play an important role in bacterial resistance (Eschenbach et al. 
1989). This hypothesis has been tested in other studies where hydrogen peroxide-producing 
lactobacilli had a protective effect against bacterial vaginosis, symptomatic candidosis and 
vaginal colonisation with genital pathogens (Hawes et al. 1996, Hillier et al. 1992). In 
support of this hypothesis one case-control study has also demonstrated that vaginal 
colonisation with E. coli occurs more frequently in females without hydrogen peroxide-
producing lactobacilli compared to females with these strains (odds ratio 4.0; p=0.01) (Gupta 
et al. 1998). In this study, spermicidal use among females correlated with an increased risk 
of vaginal colonisation with E. coli (odds ratio 12.5; p<0.001) and with the absence of 
hydrogen peroxide-producing lactobacilli. Another study also showed decreased vaginal 
lactobacilli and an increase in vaginal coliforms after nonoxynol-9 instillation in the absence 
of sexual activity and diaphragm use (Rosenstein et al. 1998). 
Based on these studies, it seems likely that the antimicrobial activity of spermicides alters 
the vaginal ecosystem and provides a suitable environment for growth and proliferation of 
uropathogens. It is interesting to note that small amounts of nonoxynol-9 on condoms can 
increase the risk of UTI in females in the absence of sexual intercourse (Fihn et al. 1998, Fihn 
et al. 1996). 
5.4 Premenopausal females  
In premenopausal healthy females sexual intercourse and spermicide use are the most 
important factors predisposing to UTIs. One study demonstrated a 2.6 fold increased risk of 
UTI in females (age 24) that have sexual intercourse 3 times a week compared to females 
that do not have intercourse (Hooton et al. 1996a). It is hypothesised that an increased risk of 
UTI from sexual intercourse occurs from trauma at the introitus (Foxman et al. 1997, Hooton 
et al. 1991b) or through mechanical introduction of the uropathogen into the bladder 
(Hooton et al. 1991b). Other predisposing factors to UTI in premenopausal patients are a 
new sexual partner during the last year, having a first UTI less than 15 years of age and 
having a mother with a history of UTIs (Hooton et al. 1996a). Interestingly, the latter two are 
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associated with a two- to four- fold increase in risk compared to normal females, perhaps 
suggesting a genetic predisposition. Finally, a previous history of UTI is a strong predictor 
of having a subsequent UTI. This may be attributable to a host’s biological or behavioural 
features or from persistent colonisation of a particular bacterial strain. 
5.5 Oestrogen  
The role of oestrogen in the pathogenesis of UTIs is controversial. In vitro studies have 
demonstrated that oestrogen permits adherence of uropthogens to vaginal epithelial cells 
(Hooton et al. 1996b). However, other studies also suggest that oestrogen deficiency in 
postmenopausal females may increase the risk of UTI (Haspels et al. 1981, Thomas et al. 
1980). In fact, one study showed that half of females aged 61 or older had genitourinary 
symptoms and 29% of this cohort also complained of urinary incontinence (Iosif and 
Bekassy 1984). Furthermore, the risk of UTI in postmenopausal females is decreased by 
topical application of oestrogen creams as demonstrated in one double-blinded-placebo 
controlled study (Raz and Stamm 1993). In this study results showed that vaginal 
colonization with E. coli was halved and lactobacillus colonization was re-established after 
topical application of oestrogen in postmenopausal females (Fig. 7). As a result vaginal pH 
was decreased along with colonisation with Enterobacteriaceae.  
 
 
Fig. 7. Proposed pathophysiology of UTIs in patients with oestrogen deficiency (Raz 2001). 
5.6 Genetic susceptibility  
Interleukin-8 is an inflammatory cytokine that promotes neutrophil migration across 
infected urothelial cells (Godaly et al. 1998, Godaly et al. 1997). Absence of its receptor 
CXCR1 has recently been shown to promote bacteraemia within the urinary tract as 
demonstrated in one study in knockout mice that lacked CXCR1 (Frendeus et al. 2001). A 
genetic predisposition to UTIs has been suggested in paediatric patients where children 
with recurrent pyelonephritis demonstrated a defect in the CXCR1 receptor (Frendeus et al. 
2000). 
5.7 Antimicrobial agents  
Animal and human studies suggest that antimicrobial agents predispose females to UTIs by 
altering their host’s vaginal ecology (Herthelius-Elman et al. 1992, Winberg et al. 1993). 
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Colonisation with E. coli is increased after administering  ǃ-lactam antimicrobial agents in 
monkeys (Herthelius-Elman et al. 1992). Notably, trimethoprim and nirofuarantoin do not 
enhance vaginal colonisation with E.coli in similar trials on monkeys and these findings 
suggest that ǃ-lactam antibiotics may be responsible for altering the genital flora of female 
patients. Less vaginal colonisation with uropathogens occurs after a course of co-
trimoxazole or fluoroquinolones when compared to ǃ-lactam antimicrobials. Finally, the 
timing of antimicrobial agents also appears to play a role for increasing the risk of UTI. One 
prospective study on premenopausal females demonstrated an increased risk for UTI in 
females that had been prescribed antimicrobial therapy during the preceding 15-28 days 
compared to the previous 3-14 days (Smith et al. 1997).   
5.8 Urological factors  
Several urological factors are associated with a predisposition to UTIs in female patients. 
Cystocele, high post-void residual volume and urinary incontinence are strongly associated 
with recurrent UTIs as demonstrated in one case control study (Raz et al. 2000). In addition, 
surgery of the genitourinary tract often precedes the onset of a UTI and urological surgery 
itself is also an independent risk factor for recurrent UTI (Raz et al. 2000). 
6. Host response to pathogenic adherence 
A series of defence pathways are activated by the host after the uropathogen adheres to the 
mucosal surface. Epithelial cells exfoliate within hours of the initial infection and infected 
urothelial cells are shed during this process (Mysorekar et al. 2002). Secretion and excretion 
of the infected urothelial cells is mediated by type 1 piliated bacteriae that induce cell 
apoptosis (Mulvey et al. 1998). In healthy patients the epithelium lining the surface of the 
bladder is quiescent as the umbrella cell layer is renewed every few months. However these 
normally repressed proliferation and differentiation cascades are rapidly activated after the 
infective process in the murine cystitis model. These proliferation cascades have the 
potential to induce effective regeneration of an umbrella cell layer within 24 hours of the 
exfoliation process (Fig. 8)  Another study in mice has demonstrated that exfoliation of 
urothelial cells prevents uropathogenic E. coli from forming clusters (Anderson et al. 2004b). 
Notably, mice that elicited a mild exfoliation process in response to the uropathogen were 
more likely to form biofilms that migrated into deeper layers.  
The host’s innate immune response is primarily responsible for providing resistance to the 
invading uropathogen. Numerous cell types such as neutrophils, macrophages, eosinophils 
and natural killer cells are activated as the uropathogen invades. In addition, 
polymorphonuclear leukocytes synthesise nitric oxide by increasing the transcription of 
nitric oxide synthase and this process has a toxic effect on the invading pathogen (Poljakovic 
and Persson 2003, Poljakovic et al. 2001). During the initial inflammatory response period it 
is important to note that neutrophils play a key role as they migrate towards the infected 
site. The migratory process is mediated by pathogen-associated molecular pattern receptors 
(PAMPs) and Toll-like receptors (TLRs) (Anderson et al. 2004b). After lipopolysaccharides 
(LPS), peptidoglycans (PG) and other bacterial products are recognised TLRs activate 
signalling pathways that initiate immune and inflammatory responses to kill pathogens 
(Anderson et al. 2004a). TLR4 and its co-receptors (CD14 and MD2) recognise Gram-
negative bacterial LPS and activate the innate immune response (Haraoka et al. 1999). In 
addition, TLR11 is released from the kidney and activated to prevent the infection from 
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ascending towards the renal parenchyma (Zhang et al. 2004). Notably, more recent studies 
have demonstrated that uropathogens can suppress NFĸB and consequentially decrease the 
host’s inflammatory response. This tactic allows the uropathogen to invade into deeper 
tissues (Klumpp et al. 2001). After 7-10 days the adaptive immune response is activated 
where specific uropathogens are recognised by B and T lymphocytes with high affinity 
antibodies. 
 
 
Fig. 8. In healthy patients the umbrella cell layer lining the lumen of the urinary bladder is 
renewed every few months (A). However, epithelial cells exfoliate within 6 hours after 
infection with an invasive uropathogen (B). This excretory process allows for effective 
excretion of infected urothelial cells. Within 24 hours of exfoliation proliferation cascades 
induce effective regeneration of a new umbrella cell layer. 
Apart from triggering the initial inflammatory response, recruited neutrophils are also 
important for providing resistance to UTIs as demonstrated in one study on mice (Haraoka 
et al. 1999). Results from this study showed that UTIs are persistent in mice with specific 
genetic backgrounds and that UTIs will resolve spontaneously in mice with normal 
backgrounds. These findings suggest that specific host genes may be important for effective 
resolution of the UTI as demonstrated in another study on mice where TLR11 recognised 
uropathogenic E. coli and prevented its ascension into the kidneys (Hopkins et al. 1998). 
Interestingly, TLR11 is truncated in humans and susceptibility for pyelonephritis is 
increased. Furthermore, a study by Mysorekar et al demonstrated that females with 
recurrent UTIs had reduced levels of CD16 which led to decreased bacterial phagocytosis 
(Mysorekar et al. 2002). 
The urinary tract is a component of the secretory immune system as it is the first defence 
system encountered by invading uropathogens. Infections of the kidneys are associated with 
serum and kidney immunoglobulin synthesis and type specific antibodies have been 
detected in the host’s urine. Serum antibodies targeting type 1 and P pili have been detected 
after episodes of pyelonephritis with IgG and SIgA antibodies also detected in the urine 
(Rene et al. 1982). Synthesis of these specific antibodies occurs locally to enhance the 
opsonisation process in infected patients and to reduce adherence of E. coli (de Ree and van 
den Bosch 1987). The potential for modifying these immunological factors to decrease the 
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incidence of UTIs in susceptible patients has been explored through immunisation 
techniques in animal models. Vaccination with P fimbria has been shown to decrease 
adherence of P-fimbriated E. coli to uroepithelial cells and prevent pyelonephritis in 
monkeys (Roberts and Phillips 1979). In addition, vaccination with FimH adhesin has been 
shown to prevent cystitis in mice (Langermann et al. 1997). It is therefore plausible that 
vaccination techniques may reduce colonisation and ascending infections in susceptible 
female patients (Uehling et al. 1994a, Uehling et al. 1994b).   
7. Conclusions  
A renewed interest in the pathogenesis of UTIs has developed over recent years. Pathogenic 
mechanisms are complicated and influenced by the biological and behavioural features of 
the host as well as adhesins from the invading uropathogen. Advances at a molecular level 
have led to a greater understanding in adherence mechanisms between bacterial virulence 
factors and the host’s uroepithelial receptors. An improved understanding of these 
pathogenic mechanisms and associated host risk factors is important for developing novel 
strategies for the treatment and prevention of UTIs.  
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